Bharat Parenterals Limited

Equities

BPLPHARMA6

INE365Y01019

Pharmaceuticals

Market Closed - Bombay S.E. 06:00:55 2024-06-26 EDT 5-day change 1st Jan Change
1,510 INR -0.18% Intraday chart for Bharat Parenterals Limited +6.26% +86.40%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Bharat Parenterals Limited agreed to acquire an unknown majority stake in Varenyam Biolifesciences Private Limited for INR 22.56 million. CI
Bharat Parenterals to Raise Stake in Subsidiary Innoxel Lifesciences MT
Bharat Parenterals Limited agreed to acquire an additional 4.89% stake in Innoxel Lifesciences Private Limited for approximately INR 650. CI
Bharat Parenterals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 CI
Bharat Parenterals Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI
Bharat Parenterals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Bharat Parenterals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Bharat Parenterals Limited Appoints Krutika Padmakar Bhattbhatt as Company Secretary and Compliance Officer CI
Bharat Parenterals Limited Announces Resignation of Shyam Singh Rajpurohit as Company Secretary and Compliance Officer CI
Bharat Parenterals Limited Declares Dividend for the Financial Year 2022 to 2023 CI
Bharat Parenterals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Bharat Parenterals Limited Recommends Final Dividend for the Financial Year Ended March 31, 2023 CI
Bharat Parenterals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023 CI
Bharat Parenterals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Bharat Parenterals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Bharat Parenterals Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Bharat Parenterals Forms New Unit MT
Bharat Parenterals Limited Reports Earnings Results for the Full Year Ended March 31, 2022 CI
Bharat Parenterals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022 CI
Bharat Parenterals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
Bharat Parenterals Limited Announces Change in Registered Office Address CI
Bharat Parenterals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021 CI
Bharat Parenterals Limited Reports Earnings Results for the First Quarter Ended June 30, 2021 CI
Bharat Parenterals' : Consolidated Profit Plunges in Fiscal Q4 MT
Bharat Parenterals Limited Announces Audited Standalone and Consolidated Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2021 CI
Chart Bharat Parenterals Limited
More charts
Bharat Parenterals Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing of pharmaceutical formulations. The Company is engaged in research, development, manufacturing, marketing, sourcing and distribution of pharmaceutical products. The Company offers a range of products, including B-lactam antibiotics, anti-retroviral, cephalosporins antibiotics, antiprotozoal / anthelmintic, respiratory, antiallergic / anti histaminic / anticold, cleansing agents/skin infections, antibiotic, cardiovascular system, anti-diabetic, anti-tuberculosis, anti-fungal, antimalarial, gastroinestinaltract / alimentary system, anti-inflammatory / anti pyretic / analgesic, supplements, central nervous system, anesthetics, anti-viral, steroids and hormones, uterine stimulant, anticancer and other. Its clients range from small biopharmaceutical startups to some pharmaceutical companies.
Calendar
More about the company
  1. Stock Market
  2. Equities
  3. BPLPHARMA6 Stock
  4. News Bharat Parenterals Limited
  5. Bharat Parenterals to Raise Stake in Subsidiary Innoxel Lifesciences